Skip to main content
. 2022 Aug 23;12:974200. doi: 10.3389/fcimb.2022.974200

Figure 7.

Figure 7

Principal component analysis (PCA) of proteomic data between the lipid rafts fractions in the control, nystatin and oseltamivir, the large vesicle fractions in the control, nystatin and oseltamivir, and the small vesicle fraction in the control, nystatin and oseltamivir.